Bioceres Crop Solutions (NASDAQ:BIOX) Lowered to Sell Rating by Wall Street Zen
by Doug Wharley · The Cerbat GemWall Street Zen cut shares of Bioceres Crop Solutions (NASDAQ:BIOX – Free Report) from a hold rating to a sell rating in a report published on Saturday.
Other analysts have also recently issued research reports about the stock. Canaccord Genuity Group dropped their price objective on shares of Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating for the company in a research note on Friday, January 2nd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Friday, March 27th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Bioceres Crop Solutions presently has a consensus rating of “Hold” and an average price target of $4.00.
Get Our Latest Stock Analysis on BIOX
Bioceres Crop Solutions Stock Performance
Shares of NASDAQ BIOX opened at $0.54 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.90 and a quick ratio of 0.69. The firm has a market cap of $34.16 million, a price-to-earnings ratio of -0.15 and a beta of 0.53. The stock’s fifty day moving average price is $0.58 and its two-hundred day moving average price is $1.21. Bioceres Crop Solutions has a one year low of $0.35 and a one year high of $5.18.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last posted its earnings results on Friday, March 13th. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.15). Bioceres Crop Solutions had a negative return on equity of 22.43% and a negative net margin of 82.83%.The firm had revenue of $73.67 million for the quarter, compared to analyst estimates of $104.55 million. On average, equities analysts forecast that Bioceres Crop Solutions will post -0.05 EPS for the current year.
Institutional Investors Weigh In On Bioceres Crop Solutions
Several institutional investors and hedge funds have recently bought and sold shares of the company. Bank of America Corp DE increased its holdings in Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after buying an additional 3,735 shares during the period. Jones Financial Companies Lllp lifted its holdings in shares of Bioceres Crop Solutions by 3,535.8% during the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after acquiring an additional 5,339 shares during the period. PDT Partners LLC boosted its position in shares of Bioceres Crop Solutions by 58.9% during the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock worth $126,000 after acquiring an additional 10,449 shares in the last quarter. Virtu Financial LLC acquired a new stake in shares of Bioceres Crop Solutions during the 3rd quarter worth approximately $40,000. Finally, Invesco Ltd. bought a new position in Bioceres Crop Solutions in the fourth quarter valued at approximately $45,000. Institutional investors own 17.68% of the company’s stock.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.
Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.